do glp 1 cause uti GLP1 Medications and Urinary Tract Infection Risks Explained GLP-1 and the kidney: from

(3) At every checkpoint (which was at 3, 6, 9, and 12 months), women on HT had a higher percentage of total body weight loss

Heerspink HJL, Karasik A, Thuresson M et al (2020) Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

Recent phase 3 TRIUMPH4 data (Dec 2025) showed 28.7% loss over 68 weeks, exceeding semaglutide (1517.5%) and tirzepatide (22.5%)

The Multifaceted Uses of L-Glutathione Reduced 1

While these medications offer substantial metabolic and cardiovascular benefits, clinicians should remain vigilant, particularly when prescribing to older patients at risk of retinal disease